Meseguer-Peinado María Antonia, Acosta-Boga Beatriz, Matas-Andreu Lurdes, Codina-Grau Gemma
Servicio de Microbiología, Hospital Universitario Ramón y Cajal, Madrid, España.
Enferm Infecc Microbiol Clin. 2012 Oct;30(8):500-4. doi: 10.1016/j.eimc.2011.10.020. Epub 2012 Apr 27.
The microbiological diagnosis of mycoplasma and ureaplasma infections has always been limited due to the fastidious growth of these microorganisms, as well as the lack of commercially prepared growth media, absence of rapid diagnostic procedures, and the clinical perception that these organisms are less significant in the infectious diseases setting. During the last few years, this situation has substantially improved due to the commercial availability of culture media, the development of rapid serological techniques, and, in particular, to the introduction of nucleic acid amplification assays, commercially available or "in-house" preparations. Despite the lack of proper standardisation and validation of the molecular and serological techniques, methodological advances have led to an increased detection of these microorganisms and, consequently, a greater appreciation of their clinical relevance.
由于支原体和脲原体生长要求苛刻,以及缺乏商业化制备的生长培养基、快速诊断程序,且临床上认为这些微生物在传染病环境中不太重要,支原体和脲原体感染的微生物学诊断一直受到限制。在过去几年中,由于培养基的商业化供应、快速血清学技术的发展,特别是核酸扩增检测方法(市售或“自制”制剂)的引入,这种情况有了很大改善。尽管分子和血清学技术缺乏适当的标准化和验证,但方法学的进步导致这些微生物的检测增加,因此对其临床相关性有了更高的认识。